Magstim Horizon Inspire Transcranial Magnetic Stimulation Device Approved by UKCA for NHS & Private UK Clinics
05 déc. 2024 04h02 HE
|
Magstim EGI
UKCA Approves Magstim Horizon Inspire TMS for NHS & Private UK Clinics. UK Made System for Patient Treatment of MDD, OCD and Decreasing Anxiety.
One Quarter of Americans Say They Are More Stressed This Holiday Season Than in 2023, Citing Financial Concerns and Missing Loved Ones
25 nov. 2024 10h37 HE
|
American Psychiatric Association
Washington, D.C., Nov. 25, 2024 (GLOBE NEWSWIRE) -- As the winter holidays approach, 28% of Americans say they are experiencing more stress related to the holiday season than they did last year, but...
PetFriendly Launches Mellow Pet Calming Products for Dogs and Cats
14 nov. 2024 09h00 HE
|
PetFriendly
OMAHA, NE, Nov. 14, 2024 (GLOBE NEWSWIRE) -- PetFriendly is excited to announce the launch of Mellow, a new line of pet calming products developed to support pet wellness both at home and on the go....
FDA Clears Magstim Horizon INSPIRE Transcranial Magnetic Stimulation System to treat Depression, OCD, Anxious Depression
12 nov. 2024 08h11 HE
|
Magstim EGI
FDA clears Magstim INSPIRE Transcranial Magnetic Stimulation TMS system to treat patients with Depression, OCD, Anxious Depression
Survey: Nearly Half of Americans Expect Their Mental Health to be Negatively Affected By the Presidential Election Result
02 nov. 2024 14h46 HE
|
Sesame
NEW YORK CITY, Nov. 02, 2024 (GLOBE NEWSWIRE) -- An annual holiday stress survey has also revealed the stakes of the upcoming presidential election in mental health terms: nearly half of the...
$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment
10 oct. 2024 10h00 HE
|
Unyte Health
The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
Social Anxiety Disorder (SAD/Social Phobia) Clinical Trials Review 2024: Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status
27 sept. 2024 06h29 HE
|
Research and Markets
Dublin, Sept. 27, 2024 (GLOBE NEWSWIRE) -- The "Social Anxiety Disorder (SAD/Social Phobia) - Global Clinical Trials Review, 2024" clinical trials has been added to ResearchAndMarkets.com's...
Manifest with a Medium Announces Launch of New Website
25 sept. 2024 09h00 HE
|
Manifest with a Medium
Los Angeles, California, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Manifest with a Medium, a platform focused on helping individuals through their manifesting state, is excited to announce the launch of...
Anxiety Disorders and Depression Treatment Global Market Report 2024-2032: Sturdy Medication Pipelines to Support Development, Economic Cost of Mental Illnesses to Drive Demand
30 août 2024 04h15 HE
|
Research and Markets
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Anxiety Disorders and Depression Treatment Global Market Report, Forecast by Product, Indication, Country and Company Analysis 2024-2032" report has...
Solace Psychology Announce New Anxiety and Depression Counselling Services in Melbourne
28 août 2024 09h00 HE
|
Solace Psychology
Carlton North, VIC, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Solace Psychology, regarded locally as the best psychologist melbourne, is happy to announce the launch of its anxiety and depression...